Research
Research outputs for the last seven years are shown below. Some long-standing staff members may have older outputs included. To see earlier years visit ORCID or Scopus
Open access indicates that an output is open access.
Year | Output |
---|---|
2024 |
Open access
4
|
2023 |
Open access
2
2
2
|
2018 |
Open access
19
19
2
|
2017 |
Open access
29
27
|
2016 |
Open access
51
49
1
|
2015 |
Open access
30
24
24
|
2015 |
Open access
33
29
3
|
2012 |
Open access
60
57
|
2011 |
Open access
43
43
|
2011 |
26
25
|
Research
Details | Registry | Status |
---|---|---|
Modulators of 14-3-3 functionality and uses thereof Woodcock, Joanna; Lopez, Angel; Pitson, Stuart M; Samuel, Michael S; Coolen, Carl |
United States | Filed |
Modulators of 14-3-3 functionality and uses thereof Woodcock, Joanna; Lopez, Angel; Pitson, Stuart; Samuel, Michael; Coolen, Carl |
WO | Filed |
External engagement & recognition
Organisation | Country |
---|---|
Australian National University | AUSTRALIA |
Biomedical Sciences Research Centre (Alexander Fleming) | AUSTRALIA |
Chinese Academy of Sciences | CHINA |
City University Of New York, Queens College | UNITED STATES |
Emory University | UNITED STATES |
La Trobe University | AUSTRALIA |
Monash University | AUSTRALIA |
Royal Adelaide Hospital | AUSTRALIA |
SA Pathology | AUSTRALIA |
St. Vincent's Institute of Medical Research | AUSTRALIA |
The Kinghorn Cancer Centre | AUSTRALIA |
The Queen Elizabeth Hospital | AUSTRALIA |
University of Adelaide | AUSTRALIA |
University of Melbourne | AUSTRALIA |
University of North Carolina at Chapel Hill | UNITED STATES |
University of South Australia | AUSTRALIA |
University of Sydney | AUSTRALIA |
Walter and Eliza Hall Institute of Medical Research | AUSTRALIA |
External engagement & recognition
Engagement/recognition | Year |
---|---|
Finalist, Unsung Hero of SA - ScienceGovernment of South Australia |
2018 |
Teaching & student supervision
Supervisions from 2010 shown
Thesis title | Student status |
---|---|
Improving the efficacy of lung cancer therapies through targeted nanomedicine | Current |
Understanding the role of 14-3-3 proteins in lung cancer initiation, progression and metastasis. | Current |